ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Crosses Below Fifty Day Moving Average – Should You Sell?

Shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) crossed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $20.43 and traded as low as $18.21. ChronoScale Corporation Common Stock shares last traded at $18.59, with a volume of 108,216 shares trading hands.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on CHRN shares. Weiss Ratings upgraded ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday. Northland Securities initiated coverage on ChronoScale Corporation Common Stock in a research report on Friday, September 18th. They issued an “outperform” rating and a $32.00 price target on the stock. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $19.00.

ChronoScale Corporation Common Stock Price Performance

The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.51 and a current ratio of 0.51. The company’s 50 day moving average price is $20.43 and its 200 day moving average price is $17.98. The company has a market cap of $2.71 billion, a price-to-earnings ratio of -3.46 and a beta of 0.98.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its earnings results on Wednesday, August 19th. The company reported ($0.12) earnings per share (EPS) for the quarter. The firm had revenue of $18.40 million for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.

Institutional Inflows and Outflows

A hedge fund recently raised its position in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc lifted its holdings in ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,338 shares of the company’s stock after acquiring an additional 1,195 shares during the quarter. Roble Belko & Company Inc owned approximately 0.07% of ChronoScale Corporation Common Stock worth $25,000 at the end of the most recent reporting period. 6.42% of the stock is currently owned by institutional investors.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.